This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of a specialty medication, ORILISSA 150 MG TABLET 7S. The contract has a ceiling value of $3,618.67 and a period of performance through December 17, 2024. It is a firm-fixed-price contract, indicating a pre-determined unit price for the medication. The contract does not have a set-aside designation, suggesting it was competitively awarded. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is likely a call against that larger IDC, enabling efficient government procurement of essential medications for military personnel, veterans, and other federal beneficiaries.
Generated 3/17/25, 9:43 AM